Genome Sequencing Identifies a Basis for Everolimus Sensitivity

Authors

+16 authors

Journal

Published

Aug 25, 2012

DOI

Save

Tip

Document

Download

Flag content

Tip

Save

Document

Download

Flag content

Abstract

Tumor genome sequencing reveals the molecular basis of a patient’s unexpected and dramatic response to a cancer drug.

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.